Association between changes in fat distribution and biomarkers for breast cancer.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authorsvan Gemert, Willemijn A
Monninkhof, Evelyn M
May, Anne M
Elias, Sjoerd G
van der Palen, Job
Stellato, Rebecca K
Schuit, Jantine A
Peeters, Petra H
MetadataShow full item record
TitleAssociation between changes in fat distribution and biomarkers for breast cancer.
Published inEndocr Relat Cancer 2017; 24(6):297-305
PubliekssamenvattingWe assessed the associations between changes in total and abdominal fat and changes in biomarkers for breast cancer risk using data of the SHAPE-2 trial. In the SHAPE-2 trial, 243 postmenopausal overweight women were included. The intervention in this trial consisted of 5-6 kg weight loss either by diet only or exercise plus diet. After 16 weeks, we measured serum sex hormones, inflammatory markers, total body fat (measured by DEXA scan) and intra and subcutaneous abdominal fat (measured by MRI). Associations between changes in different body fat depots and biomarkers were analysed by linear regression using the study cohort irrespective of randomisation to make maximal use of the distribution of changes in fat measures. We found that a loss in total body fat was associated with favourable changes in free oestradiol, free testosterone, leptin and sex hormone binding globulin (SHBG). The loss of intra-abdominal fat was associated with a decrease in free testosterone, hsCRP and leptin, and an increase in SHBG. In the multivariable analysis, the best fitted models for the biomarkers free oestradiol, SHBG leptin and adiponectin included only total body fat. For free testosterone, this was subcutaneous abdominal fat, and for hsCRP and IL-6, only intra-abdominal fat change was important. For IL-6 and adiponectin, however, associations were weak and not significant. We conclude that, in our population of healthy overweight postmenopausal women, loss of fat at different body locations was associated with changes in different types of biomarkers, known to be related to risk of breast cancer.
- Postmenopausal sex hormones in relation to body fat distribution.
- Authors: Liedtke S, Schmidt ME, Vrieling A, Lukanova A, Becker S, Kaaks R, Zaineddin AK, Buck K, Benner A, Chang-Claude J, Steindorf K
- Issue date: 2012 May
- Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial.
- Authors: van Gemert WA, Schuit AJ, van der Palen J, May AM, Iestra JA, Wittink H, Peeters PH, Monninkhof EM
- Issue date: 2015 Sep 2
- Associations between postmenopausal endogenous sex hormones and C-reactive protein: a clearer picture with regional adiposity adjustment?
- Authors: Conroy SM, Neilson HK, O'Reilly R, Woolcott CG, Stanczyk FZ, Courneya KS, Friedenreich CM
- Issue date: 2017 Sep
- The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone-binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
- Authors: Arthur RS, Dannenberg AJ, Rohan TE
- Issue date: 2021 Jul 1
- Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial.
- Authors: van Gemert WA, May AM, Schuit AJ, Oosterhof BY, Peeters PH, Monninkhof EM
- Issue date: 2016 May